Home/Filings/4/0001213900-24-019218
4//SEC Filing

Leahy Emer 4

Accession 0001213900-24-019218

CIK 0001841330other

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 9:46 PM ET

Size

6.0 KB

Accession

0001213900-24-019218

Insider Transaction Report

Form 4
Period: 2024-03-01
Leahy Emer
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-03-01+7,5007,500 total
    Exercise: $8.34Exp: 2034-02-28Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Documents

1 file

Issuer

Pasithea Therapeutics Corp.

CIK 0001841330

Entity typeother

Related Parties

1
  • filerCIK 0001875180

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 9:46 PM ET
Size
6.0 KB